HedgePath Pharmaceuticals, Inc. 4
4 · HedgePath Pharmaceuticals, Inc. · Filed Mar 10, 2017
Insider Transaction Report
Form 4
VIRCA NICHOLAS J
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2017-03-08+15,041,738→ 15,041,738 total - Tax Payment
Common Stock
2017-03-08$0.34/sh−6,314,219$2,146,834→ 8,727,519 total - Exercise/Conversion
Restricted Stock Units
2017-03-08−15,041,738→ 0 total→ Common Stock (15,041,738 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a right to receive one share of the issuer's common stock.
- [F2]The RSUs were issued to the reporting person on July 18, 2014, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms.